Silgan Holdings stock analysis
Silgan Holdings (SL3) Stock Price & Analysis
SL3 Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 3.57B
- Enterprise Value
- CHF 7.90B
- Total Cash (Recent Filing)
- CHF 324.99M
- Total Debt (Recent Filing)
- CHF 4.55B
- Price to Earnings (P/E)
- 16.3
- Beta
- 2.02
- Next Earnings
- Jan 26, 2027 (Est.)
- EPS Estimate
- 0.67
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.95%
Bulls Say, Bears Say
Bulls Say
Cash Generation
Consistently positive free cash flow and the projected increase to approximately $450 million provide internal funding for capital investment, debt management, and growth initiatives. This cash-generation profile supports financial resilience and gives management greater flexibility over the next several quarters.
Healthcare And Pharma Growth
Healthcare and pharma dispensing is becoming a sizable, fast-growing business with development and regulatory pipelines typically lasting three to five years. That extended pipeline and double-digit North American growth can broaden Silgan’s mix toward more specialized, durable packaging demand.
Operational Efficiency
The completed cost-reduction program demonstrates tangible operating discipline, with facility closures and planning improvements lowering the network’s cost base. These savings can support margins and cash generation across future periods, particularly when packaging volumes or customer demand are uneven.
Bears Say
Elevated Leverage
Debt remains substantial relative to equity, limiting financial flexibility even after leverage improved from earlier periods. High financing obligations can absorb cash that might otherwise fund investment or shareholder returns, while increasing sensitivity to weaker earnings and execution risk.
Thin And Declining Profitability
A modest and declining net margin leaves limited protection against cost, pricing, financing, or tax pressure. Net income falling below 2025 despite stronger TTM sales suggests that revenue growth is not yet translating proportionally into earnings, constraining sustainable profit expansion.
Demand And Volume Pressure
The absence of broad portfolio volume growth indicates that demand remains uneven rather than structurally accelerating. Weakness in food and beverage can constrain plant utilization and operating leverage, while growth in fragrance and pharma must expand materially to offset softer categories.
SL3 FAQ
What is Silgan Holdings’s market cap?
When is Silgan Holdings’s upcoming earnings report date?
How were Silgan Holdings’s earnings last quarter?
Is Silgan Holdings overvalued?
Does Silgan Holdings pay dividends?
What is Silgan Holdings’s EPS estimate?
How many shares outstanding does Silgan Holdings have?
What happened to Silgan Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Silgan Holdings?
What is the TipRanks Smart Score and how is it calculated?
Silgan Holdings Stock Smart Score
Company Description
Silgan Holdings
Silgan Holdings Inc., along with its affiliates, manufactures and distributes rigid packaging solutions for consumer products across North America, Europe, and other global markets. The company operates through three principal divisions. Its Metal Containers segment produces steel and aluminum cans for a wide variety of food items, such as pet food, vegetables, soups, proteins, tomato-based products, adult nutritional beverages, and fruits, in addition to general-purpose metal containers primarily for chemicals. The Dispensing and Specialty Closures segment offers an extensive selection of metal and plastic closures and advanced dispensing systems, which find application in food, beverage, healthcare, garden, home, personal care, and beauty products, as well as providing capping/sealing machinery and detection systems. Furthermore, the Custom Containers segment specializes in creating bespoke and standard plastic containers for industries including personal care, healthcare, food and beverage, household and industrial chemicals, pharmaceuticals, pet food and care, agriculture, automotive, and marine chemicals. This segment also fabricates plastic thermoformed barrier and non-barrier bowls and trays for prepared meals and pet food, along with various plastic closures, caps, sifters, fitments, and thermoformed tubs designed for food, household, and personal care products, like soft fabric wipes. Silgan markets its offerings predominantly via its dedicated sales team, complemented by a network of distributors and an online catalog. Established in 1987, the company's main office is located in Stamford, Connecticut.
- Sector
- Consumercyclical
- Industry
- Packaging & Containers
- CEO
- Adam J. Greenlee
- Employees
- 17,320
- Website
- www.silganholdings.com
- Address
- 601 Merritt Seven, Norwalk, CT, 06851, US
Silgan Holdings (SL3) Earnings & Revenues
SL3 Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Silgan reported record adjusted EPS, higher adjusted EBIT, increased full-year guidance, strong performance in fragrance, pharma, Metal Containers, and Custom Containers, and an expected increase in 2027 organic earnings and free cash flow. These positives outweighed challenges from weaker consumer demand, lower volumes in several categories, inflation, Brazil, and ongoing recovery timing for Dispensing margins.
View all CH:SL3 earnings summaries










